AbbVie Inc. - Payout Ratio History
Payout ratio history for stock ABBV (AbbVie Inc.).
| Date | Payout ratio |
|---|---|
| April 2024 | 227.94% |
| March 2024 | 227.94% |
| February 2024 | 169.86% |
| January 2024 | 169.86% |
| December 2023 | 58.04% |
| November 2023 | 56.65% |
| October 2023 | 53.38% |
| September 2023 | 53.48% |
| August 2023 | 53.38% |
| July 2023 | 53.48% |
| June 2023 | 53.48% |
| May 2023 | 53.62% |
| April 2023 | 53.29% |
| March 2023 | 53.24% |
| February 2023 | 50.77% |
| January 2023 | 50.99% |
| December 2022 | 50.99% |
| November 2022 | 47.64% |
| October 2022 | 47.59% |
| September 2022 | 40.81% |
| August 2022 | 40.37% |
| July 2022 | 40.37% |
| June 2022 | 40.37% |
| May 2022 | 46.15% |
| April 2022 | 46.15% |
| March 2022 | 40.37% |
| February 2022 | 40.37% |
| January 2022 | 37.36% |
| December 2021 | 37.36% |
| October 2021 | 140.16% |
| September 2021 | 140.16% |
| August 2021 | 178.08% |
| July 2021 | 178.08% |
| June 2021 | 178.08% |
| May 2021 | 191.18% |
| April 2021 | 191.18% |
| March 2021 | 191.18% |
| February 2021 | 113.54% |
| January 2021 | 113.54% |
| December 2020 | 93.45% |
| November 2020 | 90.78% |
| October 2020 | 90.78% |
| September 2020 | 90.78% |
| August 2020 | 75.50% |
| July 2020 | 75.50% |
| June 2020 | 75.50% |
| May 2020 | 116.30% |
| April 2020 | 116.30% |
| March 2020 | 116.30% |
| February 2020 | 116.30% |
| January 2020 | 116.30% |
| December 2019 | 116.30% |
| November 2019 | 116.30% |
| October 2019 | 116.30% |
| September 2019 | 116.30% |
| August 2019 | 116.30% |
| July 2019 | 116.30% |
| June 2019 | 116.30% |
| May 2019 | 116.30% |
| April 2019 | 116.30% |
| March 2019 | 119.55% |
| February 2019 | 119.55% |
| December 2018 | 67.80% |
| December 2017 | 60.40% |
| December 2016 | 60% |
| December 2015 | 112.90% |
| December 2014 | 71.30% |
| December 2013 | 42% |
ABBV
List: Contenders
Price: $165.87
Dividend Yield: 0.04%
Forward Dividend Yield: 3.77%
Payout Ratio: 227.94%
Dividend Per Share: 6.20 USD
Earnings Per Share: 2.72 USD
P/E Ratio: 63.54
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 6.2 million
Ebitda: 1.9 billionMarket Capitalization: 298.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 12
DGR3: 7.25%
DGR5: 8.27%
DGR10: 9.99%